ET16000091

Descriptif de l'étude : 

GO29665 A PHASE I/II, MULTICENTER, OPEN-LABEL, DOSE ESCALATION STUDY OF THE SAFETY AND PHARMACOKINETICS OF COBIMETINIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH PREVIOUSLY TREATED SOLID TUMORS

Promoteur :  ROCHE

Lien de l'étude : Clinicalstrials.gov